The Saccharomyces cerevisiae Nhp6 protein is related to the high-mobility-group B family of architectural DNA-binding proteins that bind DNA nonspecifically but bend DNA sharply. Nhp6 is involved in transcriptional activation by both RNA polymerase II (Pol II) and Pol III. Our previous genetic studies have implicated Nhp6 in facilitating TATA-binding protein (TBP) binding to some Pol II promoters in vivo, and we have used a novel genetic screen to isolate 32 new mutations in TBP that are viable in wild-type cells but lethal in the absence of Nhp6. The TBP mutations that are lethal in the absence of Nhp6 cluster in three regions: on the upper surface of TBP that may have a regulatory role, near residues that contact Spt3, or near residues known to contact either TFIIA or Brf1 (in TFIIIB). The latter set of mutations suggests that Nhp6 becomes essential when a TBP mutant compromises its ability to interact with either TFIIA or Brf1. Importantly, the synthetic lethality for some of the TBP mutations is suppressed by a multicopy plasmid with SNR6 or by an spt3 mutation. It has been previously shown that nhp6ab mutants are defective in expressing SNR6, a Pol IIItranscribed gene encoding the U6 splicing RNA. Chromatin immunoprecipitation experiments show that TBP binding to SNR6 is reduced in an nhp6ab mutant. Nhp6 interacts with Spt16/Pob3, the yeast equivalent of the FACT elongation complex, consistent with nhp6ab cells being extremely sensitive to 6-azauracil (6-AU). However, this 6-AU sensitivity can be suppressed by multicopy SNR6 or BRF1. Additionally, strains with SNR6 promoter mutations are sensitive to 6-AU, suggesting that decreased SNR6 RNA levels contribute to 6-AU sensitivity. These results challenge the widely held belief that 6-AU sensitivity results from a defect in transcriptional elongation.
The TATA-binding protein (TBP) is required for all eukaryotic transcription, whether the genes are transcribed by RNA polymerase I (Pol I), Pol II, or Pol III (28) . TBP binding to promoters of genes transcribed by Pol II correlates with transcriptional activity; therefore, regulation of TBP binding may be the critical event in determining transcriptional activation (36, 40) . Full-length TBP binds DNA slowly in a multistep process (29, 69) , and crystallographic studies demonstrate that TBP bends DNA sharply upon binding (46, 47) . Transcriptional activation by Pol II requires the assembly of a complex of general transcription factors at a promoter (18, 27) . It is believed that transcriptional coactivators function by stimulating DNA binding by TBP and facilitating formation of a complex between TBP and the general transcription factors TFIIA and TFIIB.
The Spt3 factor can regulate TBP binding to promoters. Spt3, which is part of the SAGA histone acetyltransferase complex (63) , physically interacts with TBP and plays an important role in transcriptional start site selection for RNA Pol II (19) . Spt3 can act as a positive or negative transcriptional regulator, depending on the promoter (5, 17, 67) . Although Spt3 acts to promote TBP binding at the GAL1 promoter (17), we have shown that Spt3 inhibits TBP binding to HO (67) .
Genetic interactions have been seen between SPT3 and other regulators of TBP binding (4, 13, 43) .
The Saccharomyces cerevisiae Nhp6 protein is similar to the high-mobility-group B class of architectural DNA-binding proteins (1) . Nhp6 is an abundant protein (50) , and it has multiple roles in transcription, including transcriptional initiation and elongation by Pol II and promoting transcription by Pol III. For its role in elongation, Nhp6 interacts genetically and biochemically with Spt16/Pob3 (10, 22) , the yeast equivalent of FACT that promotes elongation through chromatin templates (49) . Nhp6 is required for Spt16/Pob3 to bind to nucleosomes (22, 54) .
Nhp6 is encoded by two genes, NHP6A and NHP6B, that are functionally redundant, as only the nhp6ab double mutants show any observable phenotype. nhp6ab mutants are unable to grow at 37°C, but this growth defect can be suppressed by a multicopy plasmid with either SNR6 or BRF1 (35) . SNR6 encodes the U6 RNA required for mRNA splicing, and it is suggested that a deficiency in SNR6 RNA contributes to the temperature-sensitive growth defect seen in nhp6ab mutants. Brf1 is the limiting component in TFIIIB, a factor required for Pol III transcription (56) ; therefore, BRF1 overexpression could increase SNR6 expression and facilitate growth of the nhp6ab mutant at 37°C. Overexpression of TBP also suppresses the temperature-sensitive growth defect of an nhp6ab mutant (67) . In addition to its well-documented role in Pol II transcription, TBP is also a component of the RNA Pol III factor TFIIIB and is required for Pol III transcription (33) . Thus, TBP overexpression could suppress the nhp6ab growth defect by affecting either Pol II or Pol III transcription. Data from Paull et al. (50) suggest that Nhp6 stimulates transcription by promoting formation of preinitiation complexes.
Our genetic studies suggest that Nhp6 and the Gcn5 histone acetyltransferase function in parallel to activate expression of the yeast HO gene (67, 68) . A gcn5 nhp6a nhp6b triple mutant is extremely sick, but this growth defect can be suppressed by mutations in SIN4, SPT3, or SPT8. The data suggested that TBP was the critical target, as overexpression of TBP suppresses the temperature-sensitive growth defect of nhp6ab mutants and partially restores HO expression in the absence of either Nhp6 or Gcn5. In this study, we continue the genetic analysis examining the relationship between Nhp6 and TBP. We performed a novel synthetic lethal screen to identify strains with TBP mutations that are unable to grow in the absence of Nhp6. We also find that a multicopy plasmid with SNR6 can suppress some of the TBP nhp6ab synthetic lethalities. Our results suggest that Nhp6 and TBP work together to facilitate transcriptional activation by both Pol II and Pol III. plating assays, cells were grown to saturation in either rich or selective medium (depending on the plasmid) and washed with water, and then aliquots of diluted samples (10-fold dilutions) were plated on appropriate medium.
RESULTS
Reduced TBP binding to the SNR6 promoter in nhp6ab mutant cells. To investigate whether Nhp6 affects TBP binding to promoters in vivo, we performed ChIP assays to compare TBP binding in NHP6 and nhp6ab cells. We used PCR to examine the amount of DNA from a number of promoters transcribed by Pol II, including HO, HIS3, TRP3, URA1, ELP3, STE3, ADH2, MET14, MFA2, SER3, VID28, VPS38, and XRS2. However, none of these promoters showed a strong difference in TBP binding when immunoprecipitated material from wildtype and nhp6ab cells were compared (data not shown). It is possible that the nhp6ab mutation affects TBP binding but only modestly or that TBP binding to other Pol II promoters that we have not tested is affected.
We next examined TBP binding to the SNR6 promoter in the nhp6ab mutant. Reduced expression of SNR6, transcribed by RNA Pol III, in an nhp6ab mutant is at least partially responsible for the 37°C growth defect, as a multicopy plasmid with SNR6 can at least partially suppress this growth defect (35, 42) . We constructed isogenic strains with a TBP-Myctagged allele, either NHP6 or nhp6ab, and performed ChIP experiments. The experiment was done in duplicate, using cells grown at 30°C. Real-time PCR was used to quantitate the amount of SNR6 DNA in the immunoprecipitated chromatin. As shown in Fig. 1A , TBP-Myc shows strong binding to SNR6, compared to the untagged control strains. Importantly, binding of TBP-Myc to SNR6 was significantly reduced in the nhp6ab mutant.
The TBP-Myc-tagged nhp6ab strain shows a marked growth defect, and we have previously reported synthetic lethality between nhp6ab and hemagglutinin-tagged TBP alleles (67) . Therefore, we wanted to confirm that TBP binding to SNR6 is reduced in the nhp6ab mutant, but using a polyclonal TBP antibody instead of an epitope-tagged strain. nhp6ab mutants do not grow at 37°C, and Kruppa et al. (35) showed that shifting an nhp6ab strain to 37°C results in reduced SNR6 RNA levels. Thus, we grew wild-type and nhp6ab cells at 30°C and then shifted them to 37°C for 60 min. More than 85% of nhp6ab cells retain viability after 60 min at 37°C. Samples were taken for ChIP analysis both before and after the temperature shift. In addition to testing for TBP binding to SNR6, TBP binding to the PGK1 promoter and TRA1 open reading frame were assessed as positive and negative controls, respectively. The ChIP material was analyzed by multiplex PCR, with products separated on gels. The results show clearly that the occupancy of the SNR6 TATA element by TBP is Nhp6 dependent (Fig. 1B) . Quantitation of the SNR6 ChIP signal, normalized to the PGK1 control, shows TBP binding to SNR6 of 3 to 5.5 binding units (arbitrary units) of that in wild-type cells, while TBP binding to SNR6 is reduced in the nhp6ab mutant to We conclude that TBP binding to SNR6 is reduced in an nhp6ab mutant. Multicopy SNR6 and BRF1 suppress the 6-AU sensitivity of nhp6ab mutants. The uracil analog 6-azauracil (6-AU) inhibits transcriptional elongation by causing imbalances in the pools of ribonucleotide triphosphates (20, 57) , and some believe that mutants sensitive to 6-AU are defective in elongation. An nhp6ab mutant is very sensitive to 6-AU (10, 22) , and a concentration of 25 g of 6-AU per ml is sufficient to effectively inhibit growth ( Fig. 2A) . We wanted to know whether specific genes on multicopy plasmids will suppress this 6-AU sensitivity.
Nhp6 is required for efficient transcription of the SNR6 gene by RNA Pol III (35, 42, 44) . SNR6, the gene for U6 RNA, and BRF1, encoding a Pol III transcription factor, act as multicopy suppressors of the temperature-sensitive phenotype of nhp6ab mutants (35) . A multicopy plasmid with TBP also suppresses the temperature-sensitive growth defect of an nhp6ab mutant (67). We determined whether SNR6, BRF1, or TBP, when present on a multicopy plasmid, could suppress 6-AU sensitivity of the nhp6ab mutant (Fig. 2) . The results show strong suppression from either overexpression of the BRF1 Pol III factor or increased copies of the SNR6 structural gene. This is a surprising result, suggesting that decreased SNR6 expression contributes to the 6-AU sensitivity. Interestingly, overexpression of TBP does not suppress the 6-AU sensitivity.
It is possible that reduced SNR6 RNA levels contribute to the sensitivity to 6-AU, as the steady-state levels of SNR6 RNA are lower in an nhp6ab mutant than in wild-type cells (42) . To test this idea, we constructed strains with mutations in the SNR6 promoter that reduce expression, and these mutations result in a 6-AU-sensitive phenotype (Fig. 2B) . Interestingly, all three of these SNR6 promoter mutations are lethal in the absence of Nhp6 (44) . It is possible that the decrease in SNR6 RNA affects mRNA splicing, and this results in 6-AU sensitivity (see Discussion). Nonetheless, these experiments clearly show that sensitivity to 6-AU can result from a mutation in a gene not having a direct role in transcriptional elongation.
Screen for TBP mutations that are lethal in the absence of Nhp6. Cells containing TBP with a hemagglutinin epitope tag, whether the tag is at the N or C terminus, are viable and healthy, but the tagged versions of TBP are lethal in an nhp6ab mutant (67) . Similarly, TBP(K138T Y139A), TBP(G174E), and TBP(F237D) mutants are viable in an NHP6 ϩ strain but lethal in an nhp6ab mutant (67) . We wondered what other types of TBP mutations would not be tolerated in the absence of Nhp6, and we have taken two approaches. First, we set up a screen to look for TBP point mutations that are specifically lethal in an nhp6ab strain. Second, we tested a variety of TBP mutations that had been characterized in other labs.
We used a red and white sectoring assay (6) to identify specific TBP mutations. We constructed an ade2 ade3 spt15::LEU2 strain containing a YCp plasmid with three genes, the wild-type TBP gene and two nutritional markers, URA3 and ADE3. The SPT15 gene, which encodes TBP, is essential for viability, so this strain cannot lose the YCp-ADE3-URA3-SPT15 plasmid, and the strains are red in color and sensitive to 5-FOA. This strain was transformed with a PCR-mutagenized TBP library on a YCp-TRP1 vector (2), and we screened for solid red (nonsectoring) colonies (Fig. 3) . The majority of these nonsectoring colonies contain lethal TBP mutations, and these mutants were eliminated by mating to an NHP6 ϩ strain and testing the resulting NHP6 ϩ /nhp6ab diploids for sectoring and 5-FOA sensitivity. Finally, all of the candidate TRP1 plasmids with TBP mutations that were synthetic lethal with nhp6ab were purified and retransformed into nhp6ab spt15 and NHP6 ϩ spt15 strains to verify that the mutations are specifically lethal with nhp6ab.
We screened 8,500 colonies transformed with mutagenized TBP plasmids and recovered 32 TBP mutations that are lethal in the absence of Nhp6 (Fig. 4) . These mutants were sequenced, and all but five had a single amino acid substitution (Table 3) . We also screened 33 TBP mutants previously characterized by other investigators and identified 11 additional TBP mutations that are lethal in the absence of TBP (Table 3 ; examples in Fig. 5A ). As described below in the Discussion, these mutations cluster in three regions, near where TBP interacts with TFIIA (clusters 1, 2, and 3), where TBP interacts with Spt3 (clusters 5), and on the upper surface where the TBP core may interact with TBP-associated factors or the N-terminal region of TBP (cluster 4 [ Fig. 4] ). The TBP mutations that are tolerated in the nhp6ab mutant are interesting, and they include substitutions that eliminate interaction with TFIIB (E186L, E186 M, E188A, and L189A [38; S. Buratowski, unpublished data]) or TFIIA (K133L and K133L/K138L [11] ), substitutions that cause defective DNA binding (V71A, S118L, F148H, N159D, N159L, and V161A [2, 38, 61] ), substitutions that cause defective transcriptional activation (V71A, S118L, F148H, T153I, N159D, N159L, V161A, and E236P [2, 37] ), and substitutions that are lethal in the presence of a Taf1 truncation (S118L, N159D, N159L, V161A, and E336P [34] ).
Interestingly, two of this group of TBP point mutations that
Multicopy BRF1 or SNR6 suppresses the 6-AU sensitivity of nhp6ab mutants. (A) Dilutions of strain DY6439 transformed with the indicated plasmid were plated on plates containing complete medium or medium containing 6-AU (25 g/ml) and incubated at 30°C for 2 days (complete medium) or 6 days (medium containing 6-AU). Plasmids pRS423 (YEp-HIS3 vector), pRS423/B70 (YEp-BRF1), pRS425 (YEp-LEU2 vector), M4479 (YEp-SNR6), and M4480 (YEp-TBP) were used. (B) Dilutions of strains DY8858 (SNR6 wild type), DY8859 (SNR6-⌬42), DY8860 (SNR6-T14A), and DY8861 (SNR6-T5-flip), were plated on plates containing complete medium or medium containing 6-AU (75 g/ml) and incubated at 30°C for 2 days (complete medium) or 6 days (medium containing 6-AU). (Table 3 ) (67) . For example, the K133L K145L double mutation is lethal in the nhp6ab mutant, but cells with the K133L single mutation in TBP are viable. The K133L K145L double mutation causes defective interaction with TFIIA in vitro, and this mutant shows a much stronger growth defect than the K133L single mutant (11) . We suggest that cells with the K133L mutation have only a modest defect in interaction with TFIIA and thus tolerate the lack of Nhp6. Interestingly, while cells with the K133L mutation are viable in the absence of Nhp6, the K133R mutation recovered in the screen is lethal in the nhp6ab strain. It may be that replacement of lysine with the larger arginine residue interferes with TFIIA interaction. Suppression by multicopy SNR6. TBP interacts with TFIIA and TFIIB, and transcriptional activation requires formation of a TBP-TFIIA-TFIIB-DNA complex. We therefore asked whether a multicopy plasmid with either SUA7, encoding TFIIB, or the two genes encoding the TFIIA subunits, TOA1 and TOA2, could suppress the synthetic lethality of TBP alleles in the nhp6ab mutants. We tested more than half of the TBP mutants for multicopy suppression, but none of them were suppressed by either YEp-TFIIA or YEp-TFIIB. Since the 6-AU sensitivity of nhp6ab mutants could be suppressed by multicopy SNR6 (Fig. 2) , we determined whether YEp-SNR6 could suppress the synthetic lethality from combining nhp6ab with TBP point mutations. We tested 12 TBP alleles and found that for 8 alleles a multicopy plasmid with the SNR6 gene allowed cells to grow on 5-FOA (Table 3 ; examples in Fig. 5B ). There is no obvious correlation between the location of the TBP substitution on the structure (Fig. 4) and the ability to be suppressed by YEp-SNR6.
Suppression by spt3 mutation. Spt3 physically interacts with TBP, and Spt3 acts to promote or inhibit TBP binding, de- pending on the promoter (17, 19, 67) . Additionally, an spt3 mutation can suppress growth defects in both nhp6a nhp6b and gcn5 nhp6a nhp6b strains (67) . On the basis of these results, we examined whether an spt3 gene disruption can suppress the synthetic lethality observed between nhp6 and mutant TBP alleles, using an spt15 nhp6a nhp6b spt3 strain with wild-type TBP on a YCp-URA3 plasmid. This strain was transformed with the TRP1 plasmids carrying various mutant versions of TBP, and the transformed strains were then plated on medium containing 5-FOA to determine whether the cells were viable after loss of the YCp-URA3 plasmid with wild-type TBP. Although we did not test all of the TBP alleles that are lethal in the nhp6ab mutant, we determined that for 10 of the 19 TBP alleles tested, the spt3 mutation suppressed the synthetic lethality with nhp6ab ( Table 3) . As shown in Fig. 5C , the synthetic lethality of the F227L mutant with nhp6ab is strongly suppressed by spt3, and the F237L mutant is suppressed to a lesser extent. Again, there is no correlation between suppression by spt3 and the position of the TBP substitution on the structure (Fig. 4) . A number of the TBP mutants show temperature-sensitive growth in an otherwise wild-type (e.g., NHP6 ϩ ) strain. We decided to determine whether an spt3 mutation would affect the growth characteristics of these TBP mutants. Two isogenic spt15⌬ strains containing the YCp-ADE3-URA3-SPT15 plasmid were constructed, one SPT3 ϩ and the other spt3 Ϫ . The two strains were transformed with 15 plasmids with TBP alleles and plated at various temperatures on medium containing 5-FOA to assess the ability of these strains to grow in the absence of the plasmid with wild-type TBP. As shown in Fig. 5D , the L114F, N159D, and R220H mutants grow on 5-FOA at 30°C in both SPT3 and spt3 strains, although colony size is reduced in the spt3 mutants. All three of these TBP mutants are unable to grow on 5-FOA at an elevated temperature when the SPT3 gene is present. Interestingly, an spt3 mutation allows these TBP mutants to grow at the higher temperature. Similar suppression of temperature-sensitive growth was also seen for L172P and R173G mutants and the K97R L193S and K120I C164Y double mutants (data not shown). These suppression results are consistent with the suggestion that Nhp6 and Spt3 affect TBP function in opposing ways (67) .
Since an spt3 gene disruption can suppress many nhp6ab phenotypes, we also asked whether this suppression extends to the 6-AU sensitivity of nhp6ab mutants. As shown in Fig. 6A , the nhp6ab strain is very sensitive to 6-AU, but this effect is largely suppressed in the nhp6ab spt3 strain. This result is surprising, because the data in Fig. 2 suggest that the 6-AU sensitivity in the nhp6ab strain is largely due to the decreased expression of SNR6, a Pol III-transcribed gene. However, there is no known role of SPT3 in Pol III transcription, although the nhp6ab), and DY8855 (nhp6ab spt3) were plated on complete medium or medium containing 6-AU (25 g/ml) and incubated at 30°C for 3 days (complete medium) or 4 days (medium containing 6-AU). (B) SPT3 does not regulate SNR6 expression. RNA levels for SNR6 and SNR128 (internal control) were determined by Northern blot hybridization. RNA was isolated from strains DY3398 (wild type), DY7588 (nhp6ab), DY8980 (spt3), and DY8855 (nhp6ab spt3). (C) 6-AU causes a modest reduction in SNR6 levels. RNA levels for SNR6 and SNR128 (internal control) were determined by Northern blot hybridization. RNA was isolated from strain DY3398 (wild type) grown for 3 h at 30°C in synthetic complete medium lacking uracil containing the indicated amount of 6-AU (in micrograms per milliliter).
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on May 14, 2017 by guest http://mcb.asm.org/ function of SPT3 in Pol II transcription is well documented. To examine this question, we measured SNR6 RNA levels by Northern hybridization in isogenic strains (Fig. 6B) . SNR6 RNA levels are reduced to 23% in the nhp6ab mutant, and this value is unchanged in the nhp6ab spt3 strain. Additionally, SNR6 RNA levels are not increased in the spt3 single mutant, compared to the wild type. In wild-type strains, growth in the presence of 6-AU results in a modest decrease in SNR6 RNA levels (Fig. 6C) . In summary, the decrease in SNR6 RNA levels in the nhp6ab strain may contribute to the strong 6-AU sensitivity. However, while the spt3 mutation restores growth of the nhp6ab mutant on 6-AU, spt3 does not suppress the nhp6ab defect in SNR6 RNA levels.
DISCUSSION
Nhp6 is an abundant protein of the high-mobility-group B family of transcription factors that has been implicated in transcriptional activation by both RNA Pol II and Pol III. TBP is required for transcription by all three eukaryotic RNA polymerases. In this study, we used a novel genetic screen to identify substitutions in TBP that are viable, but lethal in the absence of Nhp6. The TBP nhp6ab synthetic lethality for a number of the TBP mutants can be suppressed by deletion of the SPT3 gene. Spt3 is known to interact directly with TBP, and spt3 mutations affect Pol II transcription start site selection (19) , suggesting that Nhp6 contributes to the activation of Pol II transcription by TBP. Nhp6 also plays an important role in transcription of the SNR6 gene by RNA Pol III, and TBP binding to SNR6 is reduced in an nhp6ab mutant. A multicopy plasmid with SNR6 suppresses the 6-AU sensitivity seen in nhp6ab mutants, as well as the lethality of some TBP substitutions in nhp6ab strains. Promoter mutations that reduce SNR6 expression also cause 6-AU sensitivity, suggesting that decreased levels of the SNR6 gene product contribute to sensitivity to this postulated inhibitor of transcriptional elongation. Our results suggest that Nhp6 and TBP work together to promote both Pol II and Pol III transcription.
TBP substitution mutants. The 43 TBP mutations that are synthetic and lethal in combination with nhp6ab cluster in interesting regions of TBP. Figure 4 shows the structure of the core of TBP, along with TFIIB, TFIIA, and DNA, merged from two separate structure determinations (48, 64) as a top view, a front view, and a 90°rotated view. New substitutions isolated in our screen that are lethal in the absence of Nhp6 are shown in red. The residues that have been previously shown to affect TBP interaction with TFIIA (K133, K138, Y139, and K145) are shown in yellow. In the TBP-TFIIA-DNA crystallographic structures, none of these four TBP residues make direct contact with TFIIA (24, 64) . Only a small part of TFIIA was successfully crystallized with TBP and DNA, and it is assumed that full-length TFIIA does indeed touch these contact residues in TBP. We show that all of these previously characterized TBP double mutants (K133L K138L, K133L K145L, and K138T Y139A) that affect interaction with TFIIA are lethal in an nhp6ab mutant but viable in an NHP6 strain. Residue K133 in TBP makes important contacts with TFIIA, as binding to TFIIA is lost in either the K133L K138L or K143 K145L double mutant (11, 62) . We also recovered a single substitution at this position, K133R, that is lethal in the absence of Nhp6. On the top surface of TBP, K133 is part of a continuous line of substitutions, E129, K151, F152,F155, I157, and R220, that are synthetic and lethal with nhp6ab, and we describe these mutations as cluster 1 (top view in Fig. 4) . Cluster 2 is a group of substitutions surrounding the other residues required for TFIIA interaction, K145 at the right edge of TBP, and slightly to the left are adjacent residues K138 and K139 (front view in Fig. 4) . New substitutions at Q144 and G147 are just above K145, and the E108, P109, K110, and I142 mutations surround K138 and K139. The cluster 3 group of mutations, K83, E93, Y94, K97, and I103, are at the interface between TBP and TFIIA defined by the crystallographic studies. Clusters 1, 2, and 3 represent regions that probably interact with TFIIA, and some interesting patterns emerge for substitutions here. An spt3 deletion suppresses the nhp6ab TBP synthetic lethality for two of four mutants tested, and three of five mutants tested can be suppressed by YEp-SNR6. These results show the important role of SPT3 and SNR6 in Nhp6 and TBP function, as discussed below.
Cluster 4 is a group of substitutions lethal in nhp6ab, including Q225, F227, E228, and Y231, that are on the upper left surface of TBP (top view in Fig. 4 ). Cluster 4 substitutions are adjacent to the P232 and V233 mutations that were identified in a screen for TBP mutations that affect NC2 binding (12) and adjacent to A226 where three mutations that specifically affect Pol II transcription were identified (14) . It is not clear what this region of TBP interacts with, but one possibility is this region interacts with factors that regulate TBP binding, such as NC2, Mot1, the Not-Ccr4 complex, and TBP-associated factors (39, 52) .
Cluster 5 is a collection of substitutions near G174, a residue that contacts Spt3 (shown in green in Fig. 4 ). Surrounding G174, we recovered clustered mutations at L172, R173, F237, and K239. Interestingly, we recovered three independent substitutions at K239. There are some interesting phenotypes common to most of the mutations in cluster 5. The synthetic lethality with nhp6ab for most of these TBP mutations can be suppressed by a spt3 deletion. Interestingly, F237L is suppressed by spt3, but not the F237D substitution at the same position. L172P and G174E can be suppressed by spt3, but not the R173G mutant at the intervening position. YEp-SNR6 suppresses the nhp6ab TBP synthetic lethality for all of the cluster 5 substitutions tested. Below cluster 5 are three residues shown in orange. These are positions where site-directed mutations were created on the TBP surface that eliminate interaction with TFIIB (38) , based on the TFIIB-TBP-DNA cocrystal. These substitutions had no additional growth defect in an nhp6ab strain.
Nhp6 and Pol III transcription. Experiments suggest that Nhp6 is required for efficient transcription of the SNR6 gene by Pol III (35, 42, 44) . SNR6 encodes the U6 RNA required for mRNA splicing, and it is suggested that a deficiency in SNR6 RNA contributes to the temperature-sensitive growth defect seen in nhp6ab mutants. Brf1 is the limiting component in TFIIIB, a factor required for Pol III transcription (56) ; therefore, BRF1 overexpression could increase SNR6 expression and facilitate growth of the nhp6ab mutant at 37°C. Overexpression of TBP also suppresses the temperature-sensitive growth defect of an nhp6ab mutant (67) . Additionally, TBP overexpression suppresses the defect in HO transcription by RNA Pol II in an nhp6ab strain (67) . In addition to its welldocumented role in Pol II transcription, TBP is also a component of the RNA Pol III factor TFIIIB and is required for Pol III transcription (33) . Thus, TBP overexpression could suppress the nhp6ab growth defect by affecting Pol II or Pol III transcription.
Several studies have defined how TBP interacts with Pol III transcription factors. Cormack and Struhl (14) mutagenized TBP, isolated substitutions with a temperature-sensitive phenotype, and identified 65 TBP mutants specifically defective in Pol III transcription. Although some of these residues also showed up in our screen for TBP nhp6ab synthetic lethality, including P65, E129, E133, Q144, F152, F155, I157, R220, Y231, and F237, not all substitutions confer the same phenotypes. For example, while F237P and F237L substitutions specifically affected Pol III transcription, F237R specifically affected Pol II, and the defects of the F237D substitution were not specific to any polymerase. Additional TBP residues important for Pol III transcription were identified through studies examining the interaction of TBP mutants with the Brf1 Pol III transcription factor (58) by the TBP-Brf1 cocrystal (32) . Interestingly, all of the residues in TFIIA that are required for TFIIA-TBP interaction (K133, K138, Y139, and K145) are also required for TBP interaction with Brf1. In summary, the regions defined by clusters 1, 2, and 3 are involved in TBP binding to both TFIIA and Brf1. The fact that these substitutions are lethal in an nhp6ab mutant suggests that Nhp6 becomes essential when a substitution reduces that ability of TBP to interact with TFIIA or Brf1.
Several of our experiments reinforce the role for Nhp6 in Pol III transcription. ChIP experiments show strong binding of TBP to the SNR6 gene, transcribed by Pol III, and TBP binding to SNR6 is markedly reduced in the absence of Nhp6. nhp6ab mutants are extremely sensitive to 6-AU, and this could be suppressed by multicopy plasmids with either the Pol III factor BRF1 or the Pol III target gene SNR6. Finally, multicopy plasmids with SNR6 suppress the nhp6ab TBP synthetic lethality for several mutants, suggesting that a defect in Pol III transcription is partially responsible for the nhp6ab TBP synthetic lethality.
The suppression of the 6-AU sensitivity in nhp6ab mutants is particularly interesting. The 6-AU inhibitor affects the ribonucleotide triphosphate pools, and many transcriptional elongation mutants are sensitive to 6-AU (20, 57) . Nhp6 interacts with the transcriptional elongation factor yFACT (Spt16/ Pob3); therefore, the 6-AU sensitivity of nhp6ab mutants was attributed to a defect in transcriptional elongation (10, 22) . We find that this 6-AU sensitivity can be suppressed by either SNR6 or BRF1 on a multicopy plasmid ( Fig. 2A) or by disruption of the SPT3 gene (Fig. 6A) . Although an spt3 mutation suppresses the 6-AU sensitivity caused by nhp6ab, spt3 does not suppress the nhp6ab defect in SNR6 expression (Fig. 6B) .
It is not clear why an spt3 gene deletion can suppress nhp6ab, in terms of sensitivity to 6-AU, but it does not suppress the defect in SNR6 expression. An spt3 mutation does not cause an increase in SNR6 RNA levels, and an spt3 strain is resistant to 6-AU (Fig. 6) . However, an spt3 mutation, by itself, has been reported to cause sensitivity to 6-AU in a different strain background (16) . Previously, SPT3 has never been shown to have a role in Pol III transcription, and spt3 mutations have been observed to affect only RNA Pol II transcription. Thus, it is possible that the spt3 suppression of the nhp6ab 6-AU sensitivity is an indirect effect of altered gene expression by RNA Pol II.
Nonetheless, our data show clearly that 6-AU sensitivity results from decreased SNR6 expression, whether because of a SNR6 promoter mutation or an nhp6ab mutation. This challenges the widely held belief that mutations affecting transcriptional elongation result in sensitivity to 6-AU. One speculative explanation is that the reduced levels of the U6 splicing factor, produced from the SNR6 gene, affect the efficiency of mRNA splicing, and this in turn has an effect on transcriptional elongation. Several reports have recently suggested a strong link between splicing and elongation. Fong and Zhou (21) report that spliceosomal small nuclear ribonucleoproteins interact with the transcription elongation factor TAT-SF1 and stimulate Pol II elongation. A mutation in the largest subunit of RNA Pol II that slows elongation by RNA Pol II has effects on splicing, in both human and Drosophila cells (15) . Additionally, mutations in the SPT4 and SPT5 yeast genes that encode elongation factors result in splicing defects (41) , and growth in the presence of 6-AU also affects splicing (30) . Additionally, growth of wild-type cells in the presence of 6-AU causes a slight reduction in SNR6 RNA levels. We suggest that the nhp6ab mutation reduces the levels of the U6 splicing factor, produced from the SNR6 gene, and that the reduced levels of splicing factors affect transcriptional elongation, resulting in 6-AU sensitivity. In any case, our studies show that one cannot assume that 6-AU sensitivity results from a defect in transcriptional elongation.
Nhp6 and Pol II transcription. While the lethality of TBP substitution mutants in an nhp6ab strain could be because Nhp6 is required for efficient SNR6 expression by RNA Pol III, we believe Nhp6 plays a role in TBP binding at genes transcribed by RNA Pol II. In vitro binding experiments show that Nhp6 stimulates the formation of a TBP-TFIIA-TFIIB-DNA complex, and in vivo experiments with chimeric promoter constructs suggest that Nhp6 acts at core promoters (50) . Nhp6 acts positively to promote activation of the HO gene (68) and negatively to repress FRE2 transcription (23). Nhp6 acts both positively and negatively at the CHA1 gene, because induced levels are reduced and basal levels are increased in an nhp6ab mutant (45) . In support of the idea that TFIIA is encoded by the TOA1 and TOA2 genes, and a toa2 mutation that eliminates TFIIA interaction with TBP is viable in wild-type cells but lethal in an nhp6ab mutant strain (Biswas et al., submitted). These results suggest that Nhp6 plays a role in formation of the TBP-TFIIA-DNA complex. Additionally, we have found genetic interactions between Nhp6 and factors that regulate TBP binding (D. Biswas and D. J. Stillman, unpublished data). These strong genetic interactions between NHP6 and basal factors exclusively used for Pol II transcription provide strong support for the idea that Nhp6 has an important role in RNA Pol II transcription. Thus, Nhp6 facilitates expression of genes transcribed by both Pol II and Pol III. 
